Fundraising Fox

CardioSignal

Turku, FI · Founded 2016 · 33 employees on LinkedIn · 5 known investors

Find your way into CardioSignal

108 people in our graph share verified history with the CardioSignal team — schools, employers, funds. One of them is your warm intro.

Detlev Biniszkiewiczunlockedknows Juuso Blomster · together at AstraZeneca (overlapped)
×9knows the team · via AstraZeneca
knows the team · via Genomill
knows the team · via Turun yliopisto - University of Turku

CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

CardioSignal was founded in 2016 by Tuomas Valtonen.

TV
Tuomas ValtonenCOO, Co-founder
JBJuuso Blomster
Juuso BlomsterinFounder, CEO
IKIlkka Korhonen
Ilkka KorhoneninChief Technology Officer
KS
Kristiina SantalahtiinResearch & Quality Director

Investors · 5

DigiTx Partners LLCSan Francisco · $2M – $5M
Innovestor VenturesHelsinki · $270K – $3.2M
SandwaterOslo · $2.2M – $11M
Start Capital
Maki.vcreportedHelsinki · $324K – $3.2M

Funding

SEC filings, press & company announcements

$10M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

CardioSignal secures $10M Series A for industry-first smartphone tech for heart disease detection - Tech.eutech.eu · Jan 2024Finnish CardioSignal raises $10M in Series A funding for smartphone-based heart disease detection - ArcticStartuparcticstartup.com · Jan 2024CardioSignal Raises $10 Million in Series A as the First Technology to Detect Major Heart Diseases without Specialized Medical Hardwarebusinesswire.com · Jan 2024CardioSignal Raises $10 Million in Series A — CardioSignalcardiosignal.com · Jan 2024CardioSignal - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.comNew investment in CardioSignal's Series Asandwater.com

Frequently asked questions

What does CardioSignal do?
CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.
Who founded CardioSignal?
CardioSignal was founded by Tuomas Valtonen in 2016.
Who are CardioSignal's investors?
CardioSignal's investors include DigiTx Partners LLC, Innovestor Ventures, Sandwater, Start Capital, Maki.vc.
How much funding has CardioSignal raised?
CardioSignal has disclosed $10M raised across 1 round.
Where is CardioSignal headquartered?
CardioSignal is headquartered in Turku, FI.